1. Home
  2. HCAC vs AVTX Comparison

HCAC vs AVTX Comparison

Compare HCAC & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCAC

Hall Chadwick Acquisition Corp Class A Ordinary Shares

N/A

Current Price

$10.01

Market Cap

292.0M

ML Signal

N/A

Logo Avalo Therapeutics Inc.

AVTX

Avalo Therapeutics Inc.

HOLD

Current Price

$16.33

Market Cap

328.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCAC
AVTX
Founded
2025
2011
Country
Singapore
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
292.0M
328.4M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
HCAC
AVTX
Price
$10.01
$16.33
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$40.57
AVG Volume (30 Days)
41.3K
2.2M
Earning Date
01-01-0001
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
72.07
EPS
N/A
N/A
Revenue
N/A
$27,813,137.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2312.27
52 Week Low
$9.92
$3.43
52 Week High
$10.06
$24.27

Technical Indicators

Market Signals
Indicator
HCAC
AVTX
Relative Strength Index (RSI) 68.72 47.87
Support Level N/A $13.70
Resistance Level N/A $19.39
Average True Range (ATR) 0.01 1.98
MACD 0.01 -0.36
Stochastic Oscillator 87.50 23.65

Price Performance

Historical Comparison
HCAC
AVTX

About HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares

Hall Chadwick Acquisition Corp is a blank check company.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

Share on Social Networks: